The Effects of Psychedelics on Fear Extinction Recall: Research From Animal Studies in a Translational Perspective
- 6:05 - 7:05
- ONLINE via Airmeet
The return of fear in patients with PTSD and anxiety who showed a marked reduction in fear during exposure therapy is a major challenge in the treatment of these disorders. One mechanism contributing to the elevated levels of fear and anxiety in patients is the deficiency of fear extinction recall. Preclinical and clinical trials showed that psychedelic-assisted psychotherapy can achieve a more long-lasting fear reduction than psychotherapy alone. Thus, it is hypothesized that improvement of fear extinction might be one important therapeutic mechanism of psychedelics.
This talk will summarize the available evidence from animal and human studies with regard to the effects of psychedelics on the recall of fear extinction. The results suggest that an enhancement of fear extinction recall through MDMA, Ayahuasca, or DMT in rodents is possible. However, the evidence is limited and, in some cases, contradictory. Relevant aspects for future studies will pointed out, such as the importance of performing a delayed fear extinction recall test to evaluate whether long-term fear reduction was effectively achieved.
Research on the clinical application of psychedelics is gaining momentum. However major knowledge gaps remain regarding the mechanisms of action underlying beneficial therapeutic effects of these s
Background: Synthesis Retreats offer a supportive environment for healthy individuals seeking personal growth and transformation through the ceremonial use of psilocybin-containing
Post‐traumatic stress disorder ﴾PTSD﴿ is characterized by intrusive, emotional memories, sympathetic hyperactivation, and trauma related avoidance. Enhanced fear learning
Mounting evidence suggests that acute effects of psychedelics (serotonergic hallucinogens) like lysergic acid diethylamide (LSD) might be elicited via altered thalamic gating, along with disturbanc